Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Prebona | PREBON | Sep 19, 2024 | 2.46 | +5.13 |
Precio Fishbone B | PRCOB | Sep 19, 2024 | 27.40 | -0.72 |
Precise Biometrics | PREC | Sep 19, 2024 | 3.84 | +9.09 |
Precomp Solutions B | PCOMB | Sep 19, 2024 | 1.22 | +0.83 |
Premium Snacks Nordic | SNX | Sep 19, 2024 | 14.80 | +2.78 |
Preservia Holding PREF | PHOLPREF | Sep 19, 2024 | 10.00 | 0.00 |
Preservia Hyresfastigheter B | PHYRB | Sep 19, 2024 | 0.12 | 0.00 |
Preservia Hyresfastigheter PREF | PHYRPREF | Sep 19, 2024 | 42.00 | 0.00 |
Preservium Property | PRESRV | Sep 19, 2024 | 50.50 | 0.00 |
Prevas B | PREVB | Sep 19, 2024 | 136.40 | -0.44 |
Pricer B | PRICB | Sep 19, 2024 | 11.06 | +3.75 |
Prisma Properties AB | PRISMA | Sep 19, 2024 | 25.35 | +1.22 |
Proact IT Group | PACT | Sep 19, 2024 | 152.80 | +1.06 |
Probi | PROB | Sep 19, 2024 | 257.00 | -2.28 |
ProfilGruppen B | PROFB | Sep 19, 2024 | 110.50 | +2.31 |
Profoto Holding | PRFO | Sep 19, 2024 | 54.60 | +2.63 |
Projektengagemang Sweden B | PENGB | Sep 19, 2024 | 12.50 | +0.40 |
Prolight Diagnostics | PRLD | Sep 19, 2024 | 0.21 | +4.52 |
Promimic AB | PRO | Sep 19, 2024 | 35.00 | 0.00 |
ProstaLund | PLUN | Sep 19, 2024 | 0.40 | +3.36 |
Prostatype Genomics | PROGEN | Sep 19, 2024 | 0.02 | -5.26 |
Provide IT | PROVIT | Sep 19, 2024 | 1.50 | +6.38 |
Purefun | PURE | Sep 19, 2024 | 10.40 | +0.97 |
Q-Linea | QLINEA | Sep 19, 2024 | 2.98 | -3.56 |
QBank | QBNK | Sep 19, 2024 | 5.95 | 0.00 |
Qbrick | QBRICK | Sep 19, 2024 | 0.22 | +15.18 |
Qiiwi Games | QIIWI | Sep 19, 2024 | 2.56 | +0.79 |
QleanAir | QAIR | Sep 19, 2024 | 25.50 | -1.16 |
Qlife Holding | QLIFE | Sep 19, 2024 | 2.82 | -2.08 |
Qliro | QLIRO | Sep 19, 2024 | 24.50 | +1.24 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.